Projects per year
Personal profile
Personal profile
Dr. Bernicker earned his medical degree from Baylor College of Medicine in Houston, TX in 1990. Subsequently, he completed his residency at Baylor Affiliated Hospitals and was chief medical resident at Ben Taub General Hospital from 1993–1994. Dr. Bernicker held a faculty appointment at Baylor College of Medicine as a clinical assistant professor from 1996–2012 before joining the Houston Methodist Cancer Center in January 2013, where he serves as director of Medical Thoracic Oncology. As a physician-scientist, Dr. Bernicker oversees the expansion of clinical trials at The Methodist Hospital relating to Thoracic Oncology with all stages of disease, a combination of SWOG trials, and industry trials of novel targeted agents.
Research interests
Dr. Bernicker’s research focuses on looking at different therapeutic approaches, such as targeted therapies and immunotherapies, in the treatment of lung cancer. By understanding how to identify patients at risk for relapse after surgery or those who can be spared the toxicities of chemotherapy, the immune system can be stimulated to preferentially destroy tumor cells, spare normal tissues, and improve patient survival along with the development of less toxic therapeutics. Eventually, the goal is to be able to offer new therapies and clinical trials to patients at Methodist with any stage of non-small cell lung cancer or small cell lung cancer.
Education/Academic qualification
Medical Oncology, Clinical Fellowship, Baylor College of Medicine
Jul 1 1994 → Sep 30 1996
Award Date: Sep 30 1996
MD, Baylor College of Medicine
May 1 1990 → Jun 1 1994
Award Date: Jun 1 1994
Internal Medicine, Residency, Baylor College of Medicine
Jan 1 1991 → Jun 30 1993
Award Date: Jun 30 1993
Internship, Dallas County Hospital -Parkland Memorial Hospital
Jan 1 1990 → Jan 1 1991
Award Date: Jan 1 1991
Research Area Keywords
- Cancer
- Clinical Translation & Trials
- Clinical Care
Free-text keywords
- Cancer research
- Lung cancer
- Targeted therapeutics
Fingerprint
Dive into the research topics where Eric H. Bernicker is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma
Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
5/2/22 → …
Project: Clinical Trial
-
Grow It Yourself: The Effect of Hydroponic Vegetable Gardening on Improving Quality of Life in Cancer Patients and Their Caregivers
2/1/22 → 7/31/22
Project: Federal Funding Agencies
-
Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy
Bernicker, E. H., Chan, E. Y., Heyne, K., Kim, M. P., Singh, M., Sultenfuss, M. A. & Zhang, J.
9/16/21 → …
Project: Clinical Trial
-
Sample and Data Collection for Houston Methodist Cancer Center Research
Chang, J. C., Bernicker, E. H., Darcourt, J., Heyne, K., Niravath, P. A. & Singh, M.
4/9/20 → …
Project: Clinical Trial
Research output
-
Contemporary trends in management of uveal melanoma
Chevli, N., Zuhour, R. J., Messer, J. A., Haque, W., Schefler, A. C., Bernicker, E. H., Chevez-Barrios, P., Farach, A. M., Butler, E. B. & Teh, B. S., 2022, In: Journal of Contemporary Brachytherapy. 14, 2, p. 123-129 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Three-year outcomes of uveal melanoma treated with intra-operative ultrasound-guided iodine-125 brachytherapy using custom-built eye plaques
Wong, A. J., Teh, B. S., Nguyen, B. T., Pino, R., Bretana, M. E., Bernicker, E. H., Chevez-Barrios, P., Butler, E. B. & Schefler, A. C., Apr 2022, In: Journal of Contemporary Brachytherapy. 14, 2, p. 130-139 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Adherence to National Comprehensive Cancer Network ALK Testing Guidelines for Patients with Advanced Non-Small Cell Lung Cancer in U.S. Community Medical Centers
Bernicker, E. H., Xiao, Y., Abraham, A., Yang, B., Croix, D. A., Redpath, S., Engstrom-Melnyk, J., Shah, R., Madala, J. & Allen, T. C., Jun 2021, In: Oncologist. 26, 6, p. e1050-e1057Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Anaplastic lymphoma kinase rearrangement prevalence in patients with advanced non-small cell lung cancer in the United States: Retrospective real world data
Allen, T. C., Xiao, Y., Yang, B., Croix, D., Abraham, A., Redpath, S., Engstrom-Melynk, J., Shah, R., Madala, J. & Bernicker, E. H., Nov 9 2021, In: Oncotarget. 12, 23, p. 2308-2315 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer
Chung, A. W., Anand, K., Anselme, A. C., Chan, A. A., Gupta, N., Venta, L. A., Schwartz, M. R., Qian, W., Xu, Y., Zhang, L., Kuhn, J., Patel, T., Rodriguez, A. A., Belcheva, A., Darcourt, J., Ensor, J., Bernicker, E., Pan, P. Y., Chen, S. H., Lee, D. J. & 2 others, , Dec 15 2021, In: Science translational medicine. 13, 624, abj5070.Research output: Contribution to journal › Article › peer-review